Fair Value of Financial Instruments - Reconciliation of the Beginning and Ending Balances Related to the Contingent Consideration (Details) - USD ($) $ in Thousands	12 Months Ended
	Dec. 31, 2021	Dec. 31, 2020	Dec. 31, 2019	Jun. 09, 2020
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration (gain) expense	$ (6,530)	$ 1,900	$ 0
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2020	76,700
Initial estimate of contingent consideration at Closing Date	10,307
Change in fair value recognized in earnings	(6,530)
Balance at December 31, 2021	80,477	76,700
Contingent consideration, liability	80,477
Contingent consideration, current portion
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2020	30,900
Balance at December 31, 2021	44,840	30,900
Contingent consideration, long term
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2020	45,800
Balance at December 31, 2021	35,637	45,800
Regulatory And Developmental Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	70,170
Sales-Based Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	10,307
Adamas Acquisition
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2020	0
Initial estimate of contingent consideration at Closing Date	10,307
Change in fair value recognized in earnings	0
Balance at December 31, 2021	10,307	0
Contingent consideration, liability	10,307
Adamas Acquisition | Regulatory And Developmental Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	0
Adamas Acquisition | Sales-Based Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	10,307
USWM Acquisition
Fair Value, Assets and Liabilities Measured on Recurring and Nonrecurring Basis [Line Items]
Contingent consideration (gain) expense	40,900
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Balance at December 31, 2020	76,700
Initial estimate of contingent consideration at Closing Date	0
Balance at December 31, 2021	70,170	$ 76,700
Contingent consideration, liability	70,170			$ 74,800
USWM Acquisition | Regulatory And Developmental Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	70,170
USWM Acquisition | Sales-Based Contingent Consideration Liability
Fair Value, Net Derivative Asset (Liability) Measured on Recurring Basis, Unobservable Input Reconciliation [Roll Forward]
Contingent consideration, liability	$ 0